Accept, and proceed to scheduling
A written Treatment Plan with dose, route, timing, follow-up schedule, and what to watch for. Scheduling begins when you're ready.
Stem cell therapy consultation: how a complex case is evaluated
For a neurologic, cardiovascular or autoimmune case, a stem cell therapy consultation at Celva is an evaluation in 5 steps: a call with a patient coordinator, your records and baseline tests, the physician team's review, an extended call if the case merits one, and a decision in writing. The decision is made on those records, never on the phone, and it can be accept, decline, or defer.
Why does the evaluation start with a call?
The call lets you, the patient or family, put the case in your own words without being rushed. You can include what you've already tried, what you're worried about, and what a meaningful outcome would look like for your family.
After it, we gather the records and baseline tests the physician team needs. That lets the team read carefully, cross-check against imaging, and consult the literature before any decision is framed.
That care buys an honest decision, not a convenient one.
What we ask for
- Diagnosis
- Imaging reports
- MRI disks
- Medication list
- Prior therapy trials
- Specialist correspondence, if available
- Baseline labs, where indicated
- What a good 12-month outcome looks like from your perspective
What happens at each step?
Case review, physician call, and written decision are included without charge.
-
Inquiry and call
A short inquiry form, then a call with a patient coordinator to understand your case, what you've tried, and what you're hoping for.
-
Records and baseline tests
You send your imaging, reports, and records, plus any baseline tests or labs we ask for after the call.
-
Physician team review
The physician team reads the case independently and rounds on it together. If the case is clearly outside scope, the answer may be no at this step.
-
Extended call
If the case merits further evaluation, an extended call follows. The physician team joins to discuss rationale, realistic expectations, and questions both ways.
-
Written decision
Accept with a Treatment Plan. Decline with reasons and referrals where appropriate. Defer for additional information.
What can the written decision say?
You receive the physician team's decision in writing, with reasons. Every case ends one of three ways.
Decline, with reasons
A written explanation of why the case doesn't fit. Where appropriate, referrals to trials, specialists, or alternate pathways.
Defer, pending information
We ask for more imaging, labs, or a specialist evaluation. The decision reopens once that information is in hand.
Questions about the process
Is there a fee for the evaluation?
No. The case review, the physician team's review, and the written decision are included without charge. We absorb that time as part of the screening these cases deserve.
Is it decided on the call?
No. The call helps us understand your case and gather what we need, but the decision is made on your records, imaging, and baseline tests, never a quick yes on the phone. That documentation is what protects the quality of the decision.
Is the decline letter final?
A decline on current evidence doesn't always stay a decline. If circumstances change (new imaging, trial eligibility, diagnosis refinement), cases can be reopened.
What if I've already had stem cell therapy elsewhere?
Tell us. Prior therapy, what was used, and what the response was becomes part of the case. It doesn't automatically disqualify you, but it matters.
Begin the evaluation
The inquiry is short. The review that follows is thorough: the physician team reads your records and baseline tests. We take the time to get the decision right.
Book a call →Not medical advice. Every candidacy undergoes careful screening.